Korro Bio Stock (NASDAQ:KRRO)
Previous Close
$46.35
52W Range
$10.29 - $76.79
50D Avg
$33.73
200D Avg
$23.68
Market Cap
$389.16M
Avg Vol (3M)
$223.35K
Beta
2.89
Div Yield
-
KRRO Company Profile
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.